Research Article | DOI: https://doi.org/10.31579/2640-1045/035
1* Associate fellow of Russian Academy of Sciences, professor, deputy director of Institute of clinical endocrinology, head of therapeutic endocrinological department, Endocrinology Research Centre.
2 Candidate of therapeutic endocrinology, Endocrinology Research Centre, Moscow, Russia.
*Corresponding Author: Troshina E.A, Associate fellow of Russian Academy of Sciences, professor, deputy director of Institute of clinical endocrinology, head of therapeutic endocrinological department, Endocrinology Research Centre.
Citation: Troshina E.A, (2018). Association of polymorphism of HLA II genes with chronic adrenal insufficiency in APS 2,3,4 types – protective and predisposing genes. J. Endocrinology and Disorders. Doi:10.31579/2640-1045/035
Copyright: © 2018 Troshina E.A . This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Received: 29 October 2018 | Accepted: 05 November 2018 | Published: 12 November 2018
Keywords: Autoimmune polyglandular syndrome 2, 3, 4 types, chronic adrenal insufficiency, genes DRB1, DQA1, DQB1 HLA class II, protective haplotypes
Endocrinology Research Centre, Moscow, Russian Federation.
This research was conducted under the research grant RSF “Autoimmune endocrinopathies multiple organ failure that are genomic, postgenomic and metabolic markers. Genetic risk prediction, monitoring, early predictors, personalized correction and rehabilitation.” Project number is 17-75-30035.
Introduction
The aim of the study was to determine the association of chronic adrenal insufficiency with polymorphism of HLA II genes among patients with APS 2,3,4 types. The focus of the study was on the revealing of protective genes for Addison’s disease in APS 3 type patients.
Materials and methods
The case-control study involved 78 patients with APS 2, 3, 4 types and 109 healthy subjects. Alleles of the HLA II class genes, CTLA4 and PTPN22 were identified by the multiprimer allele-specific PCR method. The statistical analysis was carried out using the exact two-sided Fisher test. The association of the chronic adrenal insufficiency in patients with APS was determined by the value of the odds ratio (OR - odd's ratio), the value of 95% confidence interval (95% CI).
Results
Haplotypes DR3-DQ2 (OR = 4.06), DR4-DQ8 (OR = 5.78), genotype DR3/DR4 (OR = 19.7), DQA1*0301 allele (OR = 4.27), as well as genotype DQA1*0301/DQA1*0501 (OR = 13.89) predispose to the development of APS type 2, 3 and 4 in adults compared to the control group. APS patients were divided into two groups according to the presence of Addison’s disease (APS 2 and 4 types - and type 3 APS). Haplotype DR3-DQ2 (DRB1*17-DQA1*0501-DQB1*0201) (OR = 2.6), as well as the genotype DR3/DR4 (OR = 4.28) found the strongest association with the development of adrenal insufficiency in patients with APS.
Haplotypes DRB1*01-DQA1*0101-DQB1*0501 (OR = 0.07), as well as DRB1*01 (OR = 0.08) have been determined as protective for the development of Addison’s disease.
Conclusion
Examination of APS type 3 patients without Addison’s disease for the presence of protective genes for the development of adrenal insufficiency will allow better predicting the risks of developing of the disease within the syndrome.
Autoimmune polyglandular syndromes (APS) are the combinations of a variety of autoimmune endocrine and non-endocrine diseases represented by the two main types – APS type 1 and APS type 2. Another two types - APS type 3 and APS type 4 are relating to APS of adults according to classification of clinical character [1, 5].
Nowadays in Russian practice there is no enough focus on diagnostic risks of development the new components of syndrome in APS type 3 patients. Such patients have a combination of autoimmune thyroid disorders with endocrine and non-endocrine autoimmune diseases –Type 1 Diabetes or LADA, vitiligo, alopecia, coeliacia, autoimmune atrophic gastritis, systemic lupus erythematosus, etc. excluding Addison’s disease.
The regular examination for the autoimmune markers of the new components of APS, and also revealing of predisposal and protective genes for Addison’s disease (HLA DR3, DR4) allow to predict the risk of sudden onset of complications within the syndrome (adrenal crisis and heavy forms of hypoglycemia at the onset of chronic adrenal insufficiency) [6].
The Aim of the study was to determine the association of chronic adrenal insufficiency with polymorphism of HLA II genes among patients with APS 2,3,4 types. The focus of the study was on the revealing of protective genes for Addison’s disease in APS 3 type patients.
Sera of 78 patients with APS type 2, 3, 4 and 109 healthy subjects were screened for HLA II genes’ polymorphism. APS patients were at the age of 18-78 years, women – 74,4 %, men-– 25,6 %. The control healthy group was at the age of 18-58, among them women - 64,2 %, men - 35,8 %/ The difference between two groups was not statistically significant on gender (р=0,154).
Molecular-genetic examination of HLA II genes was conducted for all patients. DNA from the whole blood of the person was carried out by set of QIAamp DNA Blood Mini Kit (QIAGEN). The method of multyprimer allele-specified polymerase chain reaction was used.
Statistical analysis was carried out by STATISTICA 10, SPSS Statistics with the use of precise two-sided Fisher’s test. The differences were considered significant with р<0> 1, inverse association with the disease - with ОR and 95 % CI <1>
Addison’s disease occurred in 46,2
A strong association of haplotypes DR3-DQ2, DR4-DQ8, especially of genotype DR3/DR4, allele DQA1*0301, and also of genotype DQA1*0301/DQA1*0501, with the development of APS of adults was confirmed.
When the groups were divided into APS with the chronic adrenal insufficiency (APS 2 and 4 types) and APS without it (APS type 3), the strongest influence on the risk of the development of chronic adrenal insufficiency in APS had haplotype DR3-DQ2 (DRB1 * 17-DQA1 * 0501-DQB1 * 0201), as well as genotype DR3 / DR4. This fact can serve as an unfavorable prognostic sign for the development of chronic adrenal insufficiency in APS type 3 and require more thorough regular screening in such patients and their relatives with autoimmune diseases.
Herewith the presence of protective haplotype DRB1*01-DQA1*0101-DQB1*0501, and also allele DRB1*01 and DRB1*13, in relation to development of chronic adrenal insufficiency in APS of adults oppositely allows to predict more favorable course of the syndrome.
Screening for the development of chronic adrenal insufficiency in APS type 3 patients is possible in standard terms - 1 time in 5 years.
Information about financing and conflict between interests.
The authors emphasize about absence of express or implied conflicts of interests, connected with conducting of this research and publication of this article.
Author contribution statement.
Troshina E.A. - formulation of the purpose and objectives of the study, development of the research concept, checking the text of the article Larina A.A. - patient recruitment, static processing of received data, writing an article
Dear Editorial Team, Clinical Medical Reviews and Reports. My experience with the journal was highly positive. The peer-review process was rigorous, constructive, and completed in a timely manner. The reviewers provided valuable comments that helped improve the quality and clarity of our manuscript. The editorial office was professional, responsive, and supportive throughout all stages of the publication process. Communication was clear and efficient, and any questions were addressed promptly. Overall, I found the journal to maintain high scientific standards and an excellent publication workflow. I would be pleased to consider submitting future work to this journal. Best wishes from, Elena Popa.
It was my pleasure to submit my testimonial concerning the Reviewer Board of our Scientific Journal “Brain and Neurological Disorders”. The Reviewers focused on some modifications and their contribution was helpful. The ladies of our Editorial Office were also supported my efforts. It was my honor to have such a co-operation and I am looking forward for more collaboration.
Dear Grace Pierce, Editorial Coordinator of Journal of Clinical Research and Reports, Thank you for the speedy and efficient peer review process. I appreciate the fact that your peer reviewers do not take months to respond like with some other journals. I would also like to thank the editorial office for responding quickly to my questions. It is an excellent journal. I plan to submit more manuscripts in the future. Best wishes from, Robert W. McGee
Dear Grace Pierce, Editorial Coordinator of Journal of Clinical Research and Reports, Working with you and your team on our recent publication in JCRR has been a truly wonderful and enjoyable experience. The responses were prompt, and the reviewers were patient, constructive, and highly professional. One reviewer in particular gave me the feeling that a professor was carefully reading and commenting on my coursework, which was deeply touching. The entire process was straightforward and hassle‑free, with no tedious online forms to complete. I highly recommend this journal. Best wishes from, DR Aibing Rao, Head of R&D
I Appreciate the Opportunity to Share my Experience with the Journal of Clinical Research and Reports. The peer review process was timely and constructive, and the feedback provided helped improve the quality of our manuscript. The editorial office was professional, responsive, and supportive throughout the process, ensuring smooth communication and efficient handling of the submission. Overall, it was a positive experience collaborating with your team.
Dear Mercy Grace, Editorial Coordinator of Obstetrics Gynecology and Reproductive Sciences, We would like to express our gratitude for your help at all stages of publishing and editing the article. The editors of the magazine answer all the necessary questions and help at every stage. We will definitely continue to cooperate and publish other works in the Obstetrics Gynecology and Reproductive Sciences! Best wishes from, Alla Konstantinovna Politova,
